Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Achromatopsia (1)
- Barriers to siRNA delivery (1)
- Blue-Yellow (1)
- Chemical modifications (1)
- Color Blindness (1)
-
- Colorblind (1)
- Colorblindness (1)
- Cones (1)
- Deuteranomaly (1)
- Deuteranopia (1)
- Dylan (1)
- Enchroma (1)
- Endosomal escape (1)
- Functional genomics (1)
- Genetics (1)
- Genome-wide association studies (1)
- Haematological cancer (1)
- Haematopoietic stem cells (1)
- Honors (1)
- Immune system activation (1)
- Ishihara (1)
- Liberty (1)
- Light (1)
- Membrane impermeability (1)
- OPN1LW (1)
- OPN1MW (1)
- OPN1SW (1)
- Off-target effects (1)
- Optics (1)
- Photopsin (1)
Articles 1 - 4 of 4
Full-Text Articles in Medical Genetics
Causes Of Color Blindness: Function And Failure Of The Genes That Detect Color, Dylan Taylor
Causes Of Color Blindness: Function And Failure Of The Genes That Detect Color, Dylan Taylor
Senior Honors Theses
Color blindness affects nearly 10% of the entire population, with multiple types of color blindness from various genetic mutations. In the following sections, the nature of light and how the human eye perceives light will be discussed. Afterward, the major forms of color blindness and their genetic causes will be considered. Once these genetic causes have been established, the current method for diagnosing color blindness will be investigated, followed by a discussion of the current treatments available to those with color blindness. Finally, a brief discussion will address possible future work for color blindness with the hope of finding better …
Inherited Causes Of Clonal Haematopoiesis In 97,691 Whole Genomes, Alexander G. Bick, Joshua S. Weinstock, Satish K. Nandakumar, Charles P. Fulco, Erik L. Bao, Seyedeh M. Zekavat, Mindy D. Szeto, Juan M. Peralta, Joanne E. Curran, John Blangero
Inherited Causes Of Clonal Haematopoiesis In 97,691 Whole Genomes, Alexander G. Bick, Joshua S. Weinstock, Satish K. Nandakumar, Charles P. Fulco, Erik L. Bao, Seyedeh M. Zekavat, Mindy D. Szeto, Juan M. Peralta, Joanne E. Curran, John Blangero
School of Medicine Publications and Presentations
Age is the dominant risk factor for most chronic human diseases, but the mechanisms through which ageing confers this risk are largely unknown1. The age-related acquisition of somatic mutations that lead to clonal expansion in regenerating haematopoietic stem cell populations has recently been associated with both haematological cancer2,3,4 and coronary heart disease5—this phenomenon is termed clonal haematopoiesis of indeterminate potential (CHIP)6. Simultaneous analyses of germline and somatic whole-genome sequences provide the opportunity to identify root causes of CHIP. Here we analyse high-coverage whole-genome sequences from 97,691 participants of diverse …
Overcoming Barriers For Sirna Therapeutics: From Bench To Bedside, Muhammad Imran Sajid, Muhammad Moazzam, Shun Kato, Kayley Yeseom Cho, Rakesh Kumar Tiwari
Overcoming Barriers For Sirna Therapeutics: From Bench To Bedside, Muhammad Imran Sajid, Muhammad Moazzam, Shun Kato, Kayley Yeseom Cho, Rakesh Kumar Tiwari
Pharmacy Faculty Articles and Research
The RNA interference (RNAi) pathway possesses immense potential in silencing any gene in human cells. Small interfering RNA (siRNA) can efficiently trigger RNAi silencing of specific genes. FDA Approval of siRNA therapeutics in recent years garnered a new hope in siRNA therapeutics. However, their therapeutic use is limited by several challenges. siRNAs, being negatively charged, are membrane-impermeable and highly unstable in the systemic circulation. In this review, we have comprehensively discussed the extracellular barriers, including enzymatic degradation of siRNAs by serum endonucleases and RNAases, rapid renal clearance, membrane impermeability, and activation of the immune system. Besides, we have thoroughly described …
Effects Of Germline And Somatic Events In Candidate Brca-Like Genes On Breast-Tumor Signatures, Weston R. Bodily, Brian H. Shirts, Tom Walsh, Suleyman Gulsuner, Mary-Claire King, Alyssa Parker, Moom Roosan, Stephen R. Piccolo
Effects Of Germline And Somatic Events In Candidate Brca-Like Genes On Breast-Tumor Signatures, Weston R. Bodily, Brian H. Shirts, Tom Walsh, Suleyman Gulsuner, Mary-Claire King, Alyssa Parker, Moom Roosan, Stephen R. Piccolo
Pharmacy Faculty Articles and Research
Mutations in BRCA1 and BRCA2 cause deficiencies in homologous recombination repair (HR), resulting in repair of DNA double-strand breaks by the alternative non-homologous end-joining pathway, which is more error prone. HR deficiency of breast tumors is important because it is associated with better responses to platinum salt therapies and PARP inhibitors. Among other consequences of HR deficiency are characteristic somatic-mutation signatures and gene-expression patterns. The term “BRCA-like” (or “BRCAness”) describes tumors that harbor an HR defect but have no detectable germline mutation in BRCA1 or BRCA2. A better understanding of the genes and molecular events associated with tumors being …